Pathomechanism of Insulin Resistance in Men with Central Obesity: Correlation of GGT, GPx, hs-CRP and Plasma Total Cysteine
Abstract
BACKGROUND: Gamma glutamyltransferase (GGT) was reported recently to be associated with inflammation, oxidative stress and increased amino acid. However, role of GGT in insulin resistance pathomechanism is not exactly known. Therefore correlation of GGT with inflammation, oxidative stress and elevated amino acid, in men with central obesity need to be confirmed.
METHODS: A cross-sectional study was designed. Men with central obesity were recruited and selected. Anthropometric parameters, creatinine, hs-CRP, fasting glucose, fasting insulin, glutathione peroxidase (GPx) activity, GGT, plasma total cysteine (tCys) and fatty liver were measured. Subjects were then divided in 4 groups based on waist circumference (WC) and fatty liver: Group I: WC ≤100 cm, without fatty liver; Group II: WC ≤100 cm, with fatty liver; Group III: WC >100 cm, without fatty liver; Group IV: WC >100 cm, with fatty liver. All biochemical characteristics in each group were then statistically analyzed.
RESULTS: Seventy-two men with central obesity were selected. Numbers of subjects in each group were: Group I: n=33; Group II: n=5; Group III: n=17; Group IV: n=17. We found significant difference of HOMA-IR between Group I and IV, significant correlation between GGT and HOMAIR, and significant negative correlation between tCys with HOMA-IR in Group IV.
CONCLUSION: GGT was significantly correlated with HOMA-IR in men with WC >100 cm and fatty liver. Further investigation with more subjects is necessary to determine clear GGT cut-off to distinguish subjects with fatty liver and insulin resistance.
KEYWORDS: GGT, hs-CRP, GPx, tCys, HOMA-IR, insulin resistance
Full Text:
PDFReferences
Kirk EP, Klein S. Pathogenesis and pathophysiology of the cardiometabolic syndrome. J Clin Hypertens. 2009; 11: 761-5, CrossRef.
Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltranferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation. 2005; 112 : 2078-80, CrossRef.
Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001; 38: 263-355, CrossRef.
Onat A, Can G, Örnek E, Çiçek G, Ayhan E, Doğan Y. Serum gamma-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome and coronary disease. Obesity. 2012; 20: 842-8, CrossRef.
Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res. 2004; 38: 535-9, CrossRef.
Giral P, Jacob N, Dourmap C, Hansel B, Carrié A, Bruckert E, et al. Elevated gamma-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008; 28: 587-93, CrossRef.
Gunawan S, Santoso A, Wijaya A. The correlation of gamma glutamyl transferase (GGT), glutathione peroxidase (GPx) and total antioxidant status (TAS) with inflammatory marker in individuals with metabolic syndrome. Indones Biomed J. 2011; 3: 57-63, CrossRef.
Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in relationship between obesity, inflammation and insulin resistance. Eur Cytokine Netw. 2006; 17: 4-12, PMID.
Tripathy D, Mohanty P, Dhindsa S, Syed T, Ghanim H, Aljada A, et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes. 2003; 52: 2882-7, CrossRef.
Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: Modulation by nutrients and inflammation. J Clin Invest. 2008; 118: 2992-3002, CrossRef.
Elshorbagy AK, Valdivia-Garcia M, Refsum H, Butte N. The association of cysteine with obesity, inflammatory cytokines and insulin resistance in Hispanic children and adolescents. Plos One. 2012; 7: e44166, CrossRef.
Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003; 107: 363-9, CrossRef.
Jialal I, Devaraj S. Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker. Am J Clin Pathol. 2001; 116 Suppl: S108-15, PMID.
Fernández-Sánchez A, Madrigal-Santillán E, Bautista M, Esquivel-Soto J, Morales-González A, Esquivel-Chirino C, et al. Inflammation, oxidative stress, and obesity. Int J Mol Sci. 2011; 12: 3117-32, CrossRef.
Forgione MA, Cap A, Liao R, Moldovan NI, Eberhardt RT, Lim CC, et al. Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structure. Circulation. 2002; 106: 1154-8, CrossRef.
Elshorbagy AK, Smith AD, Kozich V, Refsum H. Cysteine and obesity. Obesity. 2011; 20: 473-81, CrossRef.
Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocr Rev. 2008; 29: 777-822, CrossRef.
Després JP, Lemieux I,. Abdominal obesity and metabolic syndrome. Nature. 2006; 444: 881-7, CrossRef.
Nilssen O, Førde OH. Seven-year longitudinal population study of change in gamma-glutamyltransferase : the Tromso Study. Am J Epidemiol. 1994; 139: 787-92, PMID.
Kawamoto R, Kohara K, Tabara Y, Miki T, Otsuka N. Serum gammaglutamyl transferase levels are associated with metabolic syndrome in community-dwelling individuals. J Atheroscler Thromb. 2009; 16: 355-62, CrossRef.
André P, Balkau B, Vol S, Charles MA, Eschwège E, DESIR Study Group. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. Diabetes Care. 2007; 30: 2355-61, CrossRef.
Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001; 50: 1844-50, CrossRef.
DOI: https://doi.org/10.18585/inabj.v5i2.58
Copyright (c) 2013 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
